JP2024514975A5 - - Google Patents

Info

Publication number
JP2024514975A5
JP2024514975A5 JP2023565511A JP2023565511A JP2024514975A5 JP 2024514975 A5 JP2024514975 A5 JP 2024514975A5 JP 2023565511 A JP2023565511 A JP 2023565511A JP 2023565511 A JP2023565511 A JP 2023565511A JP 2024514975 A5 JP2024514975 A5 JP 2024514975A5
Authority
JP
Japan
Prior art keywords
protein
ndv
nucleotide sequence
antigen
apmv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023565511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024514975A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/026185 external-priority patent/WO2022232052A1/en
Publication of JP2024514975A publication Critical patent/JP2024514975A/ja
Publication of JP2024514975A5 publication Critical patent/JP2024514975A5/ja
Pending legal-status Critical Current

Links

JP2023565511A 2021-04-26 2022-04-25 Ａｐｍｖ ｈｎタンパク質およびｆタンパク質を発現するキメラニューカッスル病ウイルス Pending JP2024514975A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163179994P 2021-04-26 2021-04-26
US63/179,994 2021-04-26
US202263302434P 2022-01-24 2022-01-24
US63/302,434 2022-01-24
PCT/US2022/026185 WO2022232052A1 (en) 2021-04-26 2022-04-25 Chimeric newcastle disease virus expressing apmv hn and f proteins

Publications (2)

Publication Number Publication Date
JP2024514975A JP2024514975A (ja) 2024-04-03
JP2024514975A5 true JP2024514975A5 (cg-RX-API-DMAC7.html) 2025-06-04

Family

ID=83848644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565511A Pending JP2024514975A (ja) 2021-04-26 2022-04-25 Ａｐｍｖ ｈｎタンパク質およびｆタンパク質を発現するキメラニューカッスル病ウイルス

Country Status (9)

Country Link
US (1) US20240199705A1 (cg-RX-API-DMAC7.html)
EP (1) EP4329886A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024514975A (cg-RX-API-DMAC7.html)
KR (1) KR20240001198A (cg-RX-API-DMAC7.html)
AU (1) AU2022267223A1 (cg-RX-API-DMAC7.html)
CA (1) CA3215468A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023015564A2 (cg-RX-API-DMAC7.html)
MX (1) MX2023012595A (cg-RX-API-DMAC7.html)
WO (1) WO2022232052A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021229270A1 (es) 2020-05-13 2021-11-18 Laboratorio Avi-Mex, S.A. De C.V. Vacuna recombinante contra covid-19 en vector viral
CN117778471A (zh) * 2023-12-25 2024-03-29 华南农业大学 克服新城疫母源抗体影响的重组新城疫病毒载体及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112739359A (zh) * 2018-07-13 2021-04-30 西奈山伊坎医学院 Apmv及其用于治疗癌症的用途
WO2020037215A1 (en) * 2018-08-17 2020-02-20 Icahn School Of Medicine At Mount Sinai Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease

Similar Documents

Publication Publication Date Title
Huang et al. Genomic sequence of an isolate of Newcastle disease virus isolated from an outbreak in geese: a novel six nucleotide insertion in the non-coding region of the nucleoprotein gene
Kumar et al. RETRACTED: Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in Chickens
Dimmock et al. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?
Shengqing et al. Generation of velogenic Newcastle disease viruses from a nonpathogenic waterfowl isolate by passaging in chickens
Duan et al. Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases
JP2013500720A (ja) インフルエンザウイルス及びそれらの使用
JP2015119730A5 (cg-RX-API-DMAC7.html)
JP2024514975A5 (cg-RX-API-DMAC7.html)
US20190203170A1 (en) Avian Cells for Improved Virus Production
Samuel et al. Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome
Liu et al. Phylogenetic characterization and virulence of two Newcastle disease viruses isolated from wild birds in China
de Swart et al. Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines
Gao et al. Expression of transgenes from Newcastle disease virus with a segmented genome
Subbiah et al. Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses
JP2009511080A5 (cg-RX-API-DMAC7.html)
Wang et al. Rapid development of an effective newcastle disease virus vaccine candidate by attenuation of a genotype VII velogenic isolate using a simple infectious cloning system
Tan et al. Molecular characterization of three new virulent Newcastle disease virus variants isolated in China
Bankamp et al. Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay
Wei et al. Characterization of the genome sequence of an oncolytic Newcastle disease virus strain Italien
Phale Newcastle disease virus: structural and molecular basis of pathogenicity
AU2013298632B2 (en) Production of infectious influenza viruses
Von Messling et al. Toward novel vaccines and therapies based on negative-strand RNA viruses
Falk et al. Molecular characterisation of Atlantic salmon paramyxovirus (ASPV): a novel paramyxovirus associated with proliferative gill inflammation
Tsunekuni et al. Genetic comparisons between lentogenic Newcastle disease virus isolated from waterfowl and velogenic variants
Vaidya et al. Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India